chevron_left
Market & Device Trends: Chronic subdural hematoma embolization

The growing popularity of middle meningeal artery embolization in treating chronic subdural hematoma is being fueled by promising preliminary results from the EMBOLISE, STEM, and MAGIC-MT trials. This surge in physician interest is expected to drive a significant 13.6% global growth in these procedures between 2023 and 2028.